Somatomedin receptor of human placenta: solubilization, photolabeling, partial purification, and comparison with insulin receptor - PubMed (original) (raw)
Comparative Study
Somatomedin receptor of human placenta: solubilization, photolabeling, partial purification, and comparison with insulin receptor
B Bhaumick et al. Proc Natl Acad Sci U S A. 1981 Jul.
Abstract
Using a recently isolated human basic somatomedin (basic SM) similar to insulin-like growth factor I (IGF-I), we studied both the photoaffinity-labeled and unlabeled basic-SM receptor solubilized from human placental cell membranes. Unlike the result with the insulin receptor, high yields of soluble basic-SM-binding activity are obtained with Triton X-100. The soluble basic-SM receptor retains high-affinity (Kd approximately 0.3 nM) peptide-specific binding of basic SM, similar to the binding present in particulate placenta membranes; the receptor exhibits a comparatively low affinity for insulin (Kd approximately 3 microM). On Sepharose 6B, like the crude soluble insulin receptor, the basic-SM receptor migrates as a species with an apparent Stokes radius of 7.2 nm; unlike the insulin receptor, the basic-SM receptor does not, under similar conditions, yield a smaller binding species (apparent Stokes radius 3.8 nm). Upon photoaffinity labeling with 125I-labeled basic SM, one principal specifically labeled constituent is detected. Upon gel electrophoresis in the presence of 2-mercaptoethanol, the photolabeled constituent, like the insulin receptor, migrates as a species with an apparent molecular weight of about 140,000; in the absence of reducing agent, a molecular weight greater than 240,000 is observed. Lectin-agarose affinity chromatography yields a 30-fold purification both of the basic-SM-binding activity and the photolabeled constituent. Anti-insulin receptor antibody does not appear to precipitate the basic-SM receptor. We conclude that the basic-SM receptor of human placenta is a glycoprotein, remarkably similar to (an isoreceptor) but distinct from the insulin receptor previously characterized in this tissue.
Similar articles
- Characterization of the human placental receptor for basic somatomedin.
Bhaumick B, Armstrong GD, Hollenberg MD, Bala RM. Bhaumick B, et al. Can J Biochem. 1982;60(10):923-31. doi: 10.1139/o82-119. Can J Biochem. 1982. PMID: 6756616 - Comparative studies on human placental insulin and basic somatomedin receptors.
Armstrong GD, Hollenberg MD, Bhaumick B, Bala RM. Armstrong GD, et al. J Cell Biochem. 1982;20(3):283-92. doi: 10.1002/jcb.240200308. J Cell Biochem. 1982. PMID: 6302119 - The somatomedin-C receptor of human placenta.
Stuart CA, Brosnan PG, Furlanetto RW. Stuart CA, et al. Metabolism. 1984 Jan;33(1):90-6. doi: 10.1016/0026-0495(84)90168-9. Metabolism. 1984. PMID: 6318019 - Somatomedin/insulin-like growth factor tissue receptors.
Nissley SP, Rechler MM. Nissley SP, et al. Clin Endocrinol Metab. 1984 Mar;13(1):43-67. doi: 10.1016/s0300-595x(84)80008-0. Clin Endocrinol Metab. 1984. PMID: 6202447 Review. - Chemistry, structure, and function of insulin-like growth factors and their receptors: a review.
Perdue JF. Perdue JF. Can J Biochem Cell Biol. 1984 Nov;62(11):1237-45. doi: 10.1139/o84-158. Can J Biochem Cell Biol. 1984. PMID: 6098361 Review.
Cited by
- IGF/IGF-1R signal pathway in pain: a promising therapeutic target.
Ma L, Zhao W, Huang S, Xu F, Wang Y, Deng D, Zhang T, Shu S, Chen X. Ma L, et al. Int J Biol Sci. 2023 Jul 3;19(11):3472-3482. doi: 10.7150/ijbs.84353. eCollection 2023. Int J Biol Sci. 2023. PMID: 37497005 Free PMC article. Review. - Decorin inhibits the insulin-like growth factor I signaling in bone marrow mesenchymal stem cells of aged humans.
Wong TH, Chen TY, Tseng KY, Chen ZY, Chen CH, Lin FH, Wu HM, Lin S. Wong TH, et al. Aging (Albany NY). 2020 Nov 26;13(1):578-597. doi: 10.18632/aging.202166. Epub 2020 Nov 26. Aging (Albany NY). 2020. PMID: 33257596 Free PMC article. - Pharmacophore modeling for identification of anti-IGF-1R drugs and in-vitro validation of fulvestrant as a potential inhibitor.
Khalid S, Hanif R, Jabeen I, Mansoor Q, Ismail M. Khalid S, et al. PLoS One. 2018 May 22;13(5):e0196312. doi: 10.1371/journal.pone.0196312. eCollection 2018. PLoS One. 2018. PMID: 29787591 Free PMC article. - Expression and purification of functional insulin and insulin-like growth factor 1 holoreceptors from mammalian cells.
Delle Bovi RJ, Miller WT. Delle Bovi RJ, et al. Anal Biochem. 2017 Nov 1;536:69-77. doi: 10.1016/j.ab.2017.08.011. Epub 2017 Aug 19. Anal Biochem. 2017. PMID: 28830678 Free PMC article. - The three dimensional structure of the type I insulin-like growth factor receptor.
Ward CW, Garrett TP, McKern NM, Lou M, Cosgrove LJ, Sparrow LG, Frenkel MJ, Hoyne PA, Elleman TC, Adams TE, Lovrecz GO, Lawrence LJ, Tulloch PA. Ward CW, et al. Mol Pathol. 2001 Jun;54(3):125-32. doi: 10.1136/mp.54.3.125. Mol Pathol. 2001. PMID: 11376122 Free PMC article. Review.
References
- Proc Natl Acad Sci U S A. 1972 May;69(5):1277-81 - PubMed
- Biochem Pharmacol. 1973 Dec 1;22(23):3099-108 - PubMed
- J Clin Endocrinol Metab. 1974 Aug;39(2):283-92 - PubMed
- Biochem Biophys Res Commun. 1974 Dec 11;61(3):957-62 - PubMed
- Adv Protein Chem. 1976;30:251-451 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources